Loading
Immunologist and Scientific Director of the Istituto Oncologico Veneto, leading its translational cancer research.
Antonio Rosato is Scientific Director (Direttore Scientifico) of the Istituto Oncologico Veneto IRCCS and a professor of immunology at the University of Padua. His research focuses on tumour immunology and adoptive cell therapies, and he oversees the institute's research strategy, clinical trials and IRCCS scientific programmes.
| Title | Journal | Year |
|---|---|---|
| Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer | Cells | 2020 |
| The immune cell landscape of metastatic uveal melanoma correlates with overall survival | Journal of Experimental & Clinical Cancer Research | 2021 |
| The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors | Journal of Experimental & Clinical Cancer Research | 2022 |
Shares Journal of experimental & clinical cancer research and the tags leadership, clinician-scientist.
Shares Istituto Oncologico Veneto IRCCS and the tag leadership.
Shares the tags leadership, clinician-scientist, immunotherapy.
Shares Melanoma and the tags leadership, clinician-scientist, immunotherapy.
Shares Journal of experimental & clinical cancer research and the tags leadership, clinician-scientist.
Shares Journal of experimental & clinical cancer research and the tags leadership, clinician-scientist.
Shares Journal of experimental & clinical cancer research and the tags leadership, clinician-scientist.
Shares Melanoma and the tags clinician-scientist, immunotherapy.